Cerebellar ataxia is a disorder of the brain that affects body movements, coordination, muscle tone and balance. It is caused by damage to the cerebellum, a part of the brain that is important for control of movement. Symptoms of cerebellar ataxia include difficulty with balance and coordination, tremors, slurred speech, difficulty with fine motor skills, and involuntary jerking or writhing movements of limbs. In severe cases, it may cause changes in muscle tone, difficulty walking, and difficulties with speech. People with this condition may be weak and unstable when they attempt to walk, move, or stand. They may have difficulty coordinating the control of muscle movements and controlling fine movements. They may sway when attempting to stand upright, and may have difficulty turning or changing directions while walking. As the condition progresses, it may lead to sudden falls, slurred speech, and occasional seizures. In terms of diagnosis, a physical examination and medical history are the first steps taken to determine if a person has cerebellar ataxia. An MRI scan or CT scan may be necessary to visualize the brain structure and determine the cause of the disorder. Blood tests may be done to rule out other potential causes of the symptoms. Genetic testing may be done if the doctor suspects a hereditary cause. Once the diagnosis is made, a neurologist and physical therapist may be consulted to develop an appropriate treatment plan. Treatment for cerebellar ataxia is usually tailored to the individual patient and may include medications to reduce tremors and manage muscle tone, physical therapy to help increase coordination and strength, and assistive devices to help with mobility. People with this disorder may also benefit from speech and occupational therapy, as well as learning how to properly care for themselves and manage their symptoms. For some people, surgery may be necessary to correct or improve neurological problems.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom